Accumulating evidence shows that LPC is raised in inflammation-associated diseases including psoriasis [39] and that LPC exerts its effects through different signaling pathways such as NF-kB, PKC, and ERK in several cell types such as T-lymphocytes, monocytes, and neutrophils. This evidence concerns the gene NFKB1 and psoriasis.